Literature DB >> 18163433

Associations of ATF4 gene polymorphisms with schizophrenia in male patients.

Mei Qu1, Fulei Tang, Lifang Wang, Hao Yan, Yonghua Han, Jun Yan, Weihua Yue, Dai Zhang.   

Abstract

Activating transcription factor 4 (ATF4) is considered as a positional candidate gene for schizophrenia due to its location at chromosome 22q13, a region linked to schizophrenia. Furthermore, as protein interaction partner of ATF4, disrupted in schizophrenia 1 (DISC1) and its signal pathway implicated in the pathophysiology of schizophrenia have been widely supported by a number of genetic and neurobiological studies. Our aim was to investigate whether ATF4 is associated with schizophrenia in case-control samples of Han Chinese subjects consisting of 352 schizophrenia patients and 357 healthy controls. We detected 18 single nucleotide polymorphisms (SNPs) in ATF4 locus, two of which were analyzed, including one insertion at the putative core promoter region (rs17001266, -/C) and one nonsynonymous variant in exon 1 (rs4894, C/A, Pro22Gln). Allele distributions of two SNPs showed significant associations with schizophrenia in male subjects (respectively, rs17001266: P = 0.021, OR = 1.58, 95% CI = 1.07-2.33; rs4894: P = 0.004, OR = 1.78, 95% CI = 1.19-2.67), but not in female subjects as well as the entire population. Two haplotypes CC and -A constructed of rs17001266-rs4894 also revealed significant associations with schizophrenia in male group (global P = 0.0097). These findings support that ATF4 gene may be involved in susceptibility to schizophrenia with sex-dependent effect in the Chinese Han population and suggest that further functional assays are needed to verify their relevance to the pathogenesis of schizophrenia. 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18163433     DOI: 10.1002/ajmg.b.30675

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  6 in total

1.  Brain-specific disruption of the eIF2α kinase PERK decreases ATF4 expression and impairs behavioral flexibility.

Authors:  Mimi A Trinh; Hanoch Kaphzan; Ronald C Wek; Philippe Pierre; Douglas R Cavener; Eric Klann
Journal:  Cell Rep       Date:  2012-05-24       Impact factor: 9.423

2.  Association study between the pericentrin (PCNT) gene and schizophrenia.

Authors:  Shusuke Numata; Masahito Nakataki; Jun-ichi Iga; Toshihito Tanahashi; Yoshihiro Nakadoi; Kazutaka Ohi; Ryota Hashimoto; Masatoshi Takeda; Mitsuo Itakura; Shu-ichi Ueno; Tetsuro Ohmori
Journal:  Neuromolecular Med       Date:  2009-11-24       Impact factor: 3.843

Review 3.  DISC1-binding proteins in neural development, signalling and schizophrenia.

Authors:  Nicholas J Bradshaw; David J Porteous
Journal:  Neuropharmacology       Date:  2010-12-31       Impact factor: 5.250

4.  Sex differences in the genome-wide DNA methylation pattern and impact on gene expression, microRNA levels and insulin secretion in human pancreatic islets.

Authors:  Elin Hall; Petr Volkov; Tasnim Dayeh; Jonathan Lou S Esguerra; Sofia Salö; Lena Eliasson; Tina Rönn; Karl Bacos; Charlotte Ling
Journal:  Genome Biol       Date:  2014-12-03       Impact factor: 13.583

5.  HSPB1 Gene Variants and Schizophrenia: A Case-Control Study in a Polish Population.

Authors:  Malgorzata Kowalczyk; Krzysztof Kucia; Aleksander Owczarek; Renata Suchanek-Raif; Monika Paul-Samojedny; Piotr Choreza; Jan Kowalski
Journal:  Dis Markers       Date:  2022-03-15       Impact factor: 3.434

6.  Fluvoxamine alleviates ER stress via induction of Sigma-1 receptor.

Authors:  T Omi; H Tanimukai; D Kanayama; Y Sakagami; S Tagami; M Okochi; T Morihara; M Sato; K Yanagida; A Kitasyoji; H Hara; K Imaizumi; T Maurice; N Chevallier; S Marchal; M Takeda; T Kudo
Journal:  Cell Death Dis       Date:  2014-07-17       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.